Supplemental material
Journal of Medical Economics
Volume 23, 2020 - Issue 3
Open access
2,836
Views
3
CrossRef citations to date
0
Altmetric
Diabetes
Cost-effectiveness of switching to insulin degludec from other basal insulins in real-world clinical practice in Italy
Steffen HaldrupMarket Access, Novo Nordisk A/S, Søborg, Denmark; Correspondence[email protected]
, Annunziata LapollaDepartment of Medicine, Padova University, Padova, Italy
, Jens GundgaardMarket Access, Novo Nordisk A/S, Søborg, Denmark;
& Michael L. WoldenMarket Access, Novo Nordisk A/S, Søborg, Denmark;
Pages 271-279
|
Received 13 Jun 2019, Accepted 06 Sep 2019, Published online: 07 Oct 2019
Related Research Data
More Similarities Than Differences Testing Insulin Glargine 300 Units/mL Versus Insulin Degludec 100 Units/mL in Insulin-Naive Type 2 Diabetes: The Randomized Head-to-Head BRIGHT Trial
Source:
American Diabetes Association
Cost-effectiveness of switching to insulin degludec from other basal insulins in real-world clinical practice in Italy
Source:
Taylor & Francis
Cost-effectiveness of switching to insulin degludec from other basal insulins in real-world clinical practice in Italy
Source:
Informa UK Limited
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.